Trial intelligence / Profile preview

Atorvastatin vs Rosuvastatin Gel for Furcation Defects

NCT02800902Phase 3Completed

Sponsor
Government Dental College and Research Institute
Start
May 2015
Primary completion
Feb 2016
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of atorvastatin 1.2% gel, rosuvastatin 1.2% in situ gel in chronic periodontitis, sponsored by Government Dental College and Research Institute. Started May 2015; status: completed.

02

Drugs

atorvastatin 1.2% gelrosuvastatin 1.2% in situ gel
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT02800902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02800902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call